The quantity field is empty. Please enter a quantity of 1 or more to add items to your cart.
Description
Overview
A high affinity 5-HT6 Receptor antagonist (pKi = 9.0). Good solubility (to 100 mM in water or DMSO), oral availability, and penetrant to blood brain barrier. Over 200-fold selective for 5-HT6 receptors vs all receptors, ion channels and enzymes tested in Hirst et al. 2006 publication. Shows nootropic, antidepressant and axiolytic effects comparable to well-described drugs such as diazepam, and therefore has been proposed as novel treatment for schizoprenia and Alzheimer′s disease.
Wesolowska, A. et al. 2007. Pharmacol Rep.59, 664. Li, Z. et al. 2007. Brain Res.1134, 70. Hirst, et al. 2006. Eur. J. Pharm.553, 109. Routledge, C. et al. 2000. Br. J. Pharmacol.130, 1606.
Wesolowska, A. et al. 2007. Pharmacol Rep.59, 664. Li, Z. et al. 2007. Brain Res.1134, 70. Hirst, et al. 2006. Eur. J. Pharm.553, 109. Routledge, C. et al. 2000. Br. J. Pharmacol.130, 1606.
Data Sheet
Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.
A high affinity 5-HT6 Receptor antagonist (pKi = 9.0). Good solubility (to 100 mM in water or DMSO), oral availability, and penetrant to blood brain barrier. Over 200-fold selective for 5-HT6 receptors vs all receptors, ion channels and enzymes tested in Hirst et al. 2006 publication. Shows nootropic, antidepressant and axiolytic effects comparable to well-described drugs such as diazepam, and therefore has been proposed as novel treatment for schizoprenia and Alzheimer′s disease.
Form
White solid
CAS number
402713-80-8
Chemical formula
C₁₈H₂₁Cl₂N₃O₄S·HCl
Structure formula
Purity
≥99% by HPLC
Solubility
DMSO (100 mM) or H₂O (100 mM)
Storage
Protect from light
+2°C to +8°C
Do Not Freeze
Ok to freeze
Special Instructions
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity
Standard Handling
References
Wesolowska, A. et al. 2007. Pharmacol Rep.59, 664. Li, Z. et al. 2007. Brain Res.1134, 70. Hirst, et al. 2006. Eur. J. Pharm.553, 109. Routledge, C. et al. 2000. Br. J. Pharmacol.130, 1606.